Tecfidera
Named-patient access overview. Tecfidera is coordinated by Reserve Meds for international patients via physician-led cross-border sourcing.
Quick orientation
Tecfidera (dimethyl fumarate) is an oral fumaric acid ester developed by Biogen that is thought to act primarily through activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant response pathway and modulation of pro-inflammatory cytokine signalling. The US Food and Drug Administration approved Tecfidera in March 2013 for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Dosing is initiated at 120 mg by mouth twice daily for the first seven days, then increased to the maintenance dose of 240 mg twice daily, taken with or without food. Tecfidera is prescribed by neurology and managed in an outpatient setting, with periodic complete blood counts and clinical monitoring for lymphopenia and the rare risk of progressive multifocal leukoencephalopathy.
Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.
How Reserve Meds coordinates Tecfidera
- Patient or treating physician submits an intake at the patient portal.
- Reserve Meds clinical team verifies appropriateness for the patient and destination country.
- Treating physician issues prescription and clinical justification.
- Country-specific named-patient documentation is prepared.
- Tecfidera is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
- Shipment is coordinated to the patient's physician or hospital pharmacy with appropriate handling.
Access by country
Reserve Meds publishes a detailed country access guide for Tecfidera in every market we coordinate. Each page below covers the destination-country regulatory pathway, real costs, indicative timelines, physician-credential requirements, and handling notes. Tap any country to read the full deep-dive.
Start a request for Tecfidera
Submit a 60-second intake. The clinical team will follow up within 24 hours with case-specific feasibility, timeline, and a formal quote.
Frequently asked questions
How can I get Tecfidera if it is not approved or available in my country?
Reserve Meds coordinates US-sourced Tecfidera for patients through a physician-led, named-patient cross-border pathway. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for your country and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Tecfidera through named-patient or compassionate-use import?
Yes. Named-patient access (also called compassionate use or personal import) is the core route Reserve Meds operates for Tecfidera. Eligibility and paperwork depend on the regulator in your country, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Tecfidera through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Tecfidera to a patient?
Reserve Meds sources Tecfidera from a DSCSA-compliant US specialty supplier with full traceability and coordinates delivery to your treating physician or hospital pharmacy, with appropriate handling for the product.
How long does it take, and what does Tecfidera cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Tecfidera?
Submit a 60-second intake through the Reserve Meds patient portal, or message the concierge team on WhatsApp. A named coordinator follows up within 24 hours.